Lymphoma (non Hodgkin's) - bendamustine (with rituximab) [ID434]

  • Discontinued
  • GID-TAG278

Documents

Documents created during the development process.

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): final scope

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): final matrix

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): NICE response to consultee and commentator comments on the draft scope

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): equality impact assessment - scoping

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): draft scope for consultation (post referral) October 2012

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): draft matrix for consultation (post referral) October 2012

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): draft scope for consultation (pre-referral) August 2010

Lymphoma (non Hodgkin's) - bendamustine (with rituximab): provisional matrix (pre-referral) August 2010